SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Mycotopia Therapies, Inc. – ‘10-Q’ for 6/30/20 – ‘EX-32.1’

On:  Wednesday, 8/19/20, at 2:22pm ET   ·   For:  6/30/20   ·   Accession #:  1445866-20-1242   ·   File #:  0-56022

Previous ‘10-Q’:  ‘10-Q’ on 5/18/20 for 3/31/20   ·   Next:  ‘10-Q’ on 11/16/20 for 9/30/20   ·   Latest:  ‘10-Q’ on 11/13/23 for 9/30/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 8/19/20  20/20 Global, Inc.                10-Q        6/30/20   46:1.9M                                   C Filings/FA

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        20/20 Global, Inc. - Form 10-Q SEC Filing           HTML    329K 
 2: EX-31.1     Certification -- §302 - SOA'02                      HTML     18K 
 3: EX-32.1     Certification -- §906 - SOA'02                      HTML     15K 
10: R1          Document and Entity Information                     HTML     64K 
11: R2          Condensed Consolidated Balance Sheets               HTML     79K 
12: R3          Condensed Consolidated Balance Sheets -             HTML     28K 
                Parenthetical                                                    
13: R4          Condensed Consolidated Statements of Operations     HTML     74K 
14: R5          Condensed Consolidated Statements of Changes in     HTML     40K 
                Stockholders' Equity                                             
15: R6          Condensed Consolidated Statements of Cash Flows     HTML     67K 
16: R7          Note 1 - Organization and Description of Business   HTML     19K 
17: R8          Note 2 - Summary of Significant Accounting          HTML     25K 
                Policies                                                         
18: R9          Note 3 - Going Concern                              HTML     18K 
19: R10         Note 4 - Related-Party Transactions                 HTML     19K 
20: R11         Note 5 - Employer Ira Plan                          HTML     18K 
21: R12         Note 6 - Legal Proceeding                           HTML     18K 
22: R13         Note 7 - Discontinued Operations                    HTML     79K 
23: R14         Note 8 - Subsequent Events                          HTML     18K 
24: R15         NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING          HTML     18K 
                POLICIES: Basis of Presentation (Policies)                       
25: R16         NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING          HTML     18K 
                POLICIES: Basis of Consolidation (Policies)                      
26: R17         NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING          HTML     19K 
                POLICIES: Use of Estimates (Policies)                            
27: R18         NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING          HTML     18K 
                POLICIES: Cash and Cash Equivalents (Policies)                   
28: R19         NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING          HTML     19K 
                POLICIES: Accounts Receivable and Doubtful                       
                Accounts (Policies)                                              
29: R20         NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING          HTML     20K 
                POLICIES: Revenue Recognition (Policies)                         
30: R21         NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING          HTML     18K 
                POLICIES: Fair Value of Financial Instruments                    
                (Policies)                                                       
31: R22         NOTE 7 - DISCONTINUED OPERATIONS: Schedule of       HTML     29K 
                Discontinued Operations - Assets (Tables)                        
32: R23         NOTE 7 - DISCONTINUED OPERATIONS: Schedule of       HTML     61K 
                Discontinued Operations - Income (Tables)                        
33: R24         NOTE 7 - DISCONTINUED OPERATIONS: Schedule of       HTML     25K 
                Discontinued Operations - Cash flows (Tables)                    
34: R25         Note 1 - Organization and Description of Business   HTML     17K 
                (Details)                                                        
35: R26         NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING          HTML     20K 
                POLICIES: Accounts Receivable and Doubtful                       
                Accounts (Details)                                               
36: R27         Note 3 - Going Concern (Details)                    HTML     19K 
37: R28         Note 4 - Related-Party Transactions (Details)       HTML     19K 
38: R29         Note 5 - Employer Ira Plan (Details)                HTML     19K 
39: R30         Note 6 - Legal Proceeding (Details)                 HTML     17K 
40: R31         NOTE 7 - DISCONTINUED OPERATIONS: Schedule of       HTML     33K 
                Discontinued Operations - Assets (Details)                       
41: R32         NOTE 7 - DISCONTINUED OPERATIONS: Schedule of       HTML     51K 
                Discontinued Operations - Income (Details)                       
42: R33         NOTE 7 - DISCONTINUED OPERATIONS: Schedule of       HTML     29K 
                Discontinued Operations - Cash flows (Details)                   
44: XML         IDEA XML File -- Filing Summary                      XML     80K 
 9: XML         XBRL Instance -- twgl-20200630_htm                   XML    394K 
43: EXCEL       IDEA Workbook of Financial Reports                  XLSX     40K 
 4: EX-101.CAL  XBRL Calculations -- twgl-20200630_cal               XML     63K 
 5: EX-101.DEF  XBRL Definitions -- twgl-20200630_def                XML     79K 
 6: EX-101.LAB  XBRL Labels -- twgl-20200630_lab                     XML    336K 
 7: EX-101.PRE  XBRL Presentations -- twgl-20200630_pre              XML    267K 
 8: EX-101.SCH  XBRL Schema -- twgl-20200630                         XSD     76K 
45: JSON        XBRL Instance as JSON Data -- MetaLinks              141±   197K 
46: ZIP         XBRL Zipped Folder -- 0001445866-20-001242-xbrl      Zip     54K 


‘EX-32.1’   —   Certification — §906 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C: 

Exhibit 32.01

 

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

 

In connection with the Quarterly Report of 20/20 Global, Inc. (the “Company”) on Form 10-Q for the quarter ended June 30, 2020, as filed with the Securities and Exchange Commission (the “Report”), I, Mark D. Williams, Chief Executive Officer and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

 

(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and 

 

(2)the information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company

 

/s/ Mark D. Williams

Mark D. Williams

Chief Executive Officer

Chief Financial Officer

August 19, 2020

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.



Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘10-Q’ Filing    Date    Other Filings
Filed on:8/19/20
For Period end:6/30/20NT 10-Q
 List all Filings 
Top
Filing Submission 0001445866-20-001242   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Wed., May 1, 12:02:59.1am ET